Pharmaceutical Company Settles Shareholder Class Action

A pharmaceutical company defended a securities fraud shareholder class action challenging the company's valuation of auction rate securities. Our firm represented the company, obtaining court approval of a class-wide settlement of less than $2 million. 

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.